SecBot SecBot
6-K ·Filed Jul 24, 2026

QTEX

QTREX Quantum Ltd.
NEUTRAL
Impact 5/10
Horizonweeks Processed3mo ago SEC0001185185-26-003120
Notable filing: 6-K
Actionable Insight • Neutral

The most significant item is Proposal 11, which would entrench the board via a staggered structure and enable a poison pill. Passage would make a hostile takeover significantly more difficult. Monitor the shareholder vote outcome on August 28, 2026; if Proposal 11 passes, the stock's vulnerability to activist or takeover approaches is materially reduced. The tripling of authorized shares (Proposal 10) also provides a potential dilutive overhang for future financings.

DirectionNeutral
Confidencehigh
Horizonweeks

How the stock moved after the report

NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$0.9497
T+0 close · Jul 24, 2026 · via day close
Latest settled
+47.41%
T+60 · $1.40
Vs SPY
+43.71%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Jul 27 $0.9497entry
  2. T+1 · 4mo ago −8.09%α −8.33% · $0.8729
  3. T+5 · 4mo ago −5.23%α −6.31% · $0.9000
  4. T+20 · 3mo ago −8.77%α −12.07% · $0.8664
  5. T+60 · 28d ago +47.41%α +43.71% · $1.40
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

QTREX Quantum Ltd. filed a 6-K furnishing its proxy statement for the Annual and Extraordinary General Meeting on August 28, 2026. The meeting agenda includes routine items (auditor re-appointment, director elections, compensation policy renewal) and a significant governance overhaul: Proposal 11 seeks to adopt a staggered board, a shareholder rights plan, and an exclusive forum clause, all requiring a 70% supermajority vote. The filing also proposes a tripling of authorized shares from 100M to 300M, providing flexibility for future capital needs. This is a governance-focused filing with no financial results, making it neutral in sentiment but notable for the anti-takeover provisions.

Key Facts

  • Meeting scheduled for August 28, 2026, to vote on 11 proposals.
  • Proposal 11 seeks to implement a staggered board (3 classes, 3-year terms), a shareholder rights plan, and an exclusive forum clause.
  • Proposal 10 seeks to increase authorized share capital from 100M to 300M ordinary shares.
  • Proposal 3 seeks approval of an updated compensation policy for a 3-year term, including provisions for equity in lieu of salary.
  • Proposals 4-9 seek approval of increased fees and RSU grants for the CEO, Chairman, and non-executive directors.
  • Proposal 11 requires a 70% supermajority vote of shares present and voting to pass.
  • The filing is a proxy solicitation for an annual meeting; no financial results are reported.

Financial Impact

No financial results reported. The filing proposes increasing authorized share capital from 100M to 300M shares and approving executive compensation changes, including RSU grants valued at approximately $527,589 each for the CEO and Chairman.

dilutionauthorized sharesexecutive compensation

Risk Factors

  • Passage of Proposal 11 (staggered board and rights plan) would entrench management and reduce the likelihood of a successful hostile takeover.
  • Approval of Proposal 10 (increase in authorized shares) creates potential for future dilutive equity issuances without further shareholder vote.
  • The proposed RSU grants to executives and directors will result in future dilution as shares vest.
  • The updated compensation policy allows for exchanging accrued salary for equity at a discount of up to 50%, which could be dilutive.

Market Snapshot

Exchange
Nasdaq
Sector
Surgical & Medical Instruments & Apparatus
Analyst Consensus
86% bullish (7 analysts)

Documents Analyzed

This report is based on 5 SEC documents filed with EDGAR.

DocumentAccession Number
6-K Filing (Primary)0001185185-26-003120
Document: qtrex6k072326.htm0001185185-26-003120
Document: 0001185185-26-003120-index-headers.html0001185185-26-003120
Document: 0001185185-26-003120-index.html0001185185-26-003120
Document: 0001185185-26-003120.txt0001185185-26-003120

Track record

28 reports on QTEX

Performance horizon

6 of 8 bullish or bearish reports moved the stock their way by T+5. Best: +115.29% at T+5 after the Oct 1, 2026 report. 7 of 8 went positive at some point.

Filters
  1. Nov 16, 2026today SC 13G/A Bearish 5/10 Entry $1.19 Now $1.15 +3.35% settles Nov 23
  2. Nov 16, 2026today Press Release Neutral 4/10 Entry $1.22 Now $1.15 −5.74% settles Nov 23
  3. Nov 12, 20264d ago Press Release Neutral 3/10 Entry $1.19 Now $1.15 −3.36% settles Nov 19
  4. Oct 19, 202628d ago 6-K Neutral 3/10 Entry $1.40 to $1.29 Now $1.15 −17.86% ▼ −7.86% −7.71% vs SPY
  5. Oct 19, 202628d ago Press Release Neutral 3/10 Entry $1.40 to $1.29 Now $1.15 −17.86% ▼ −8.21% −8.07% vs SPY
  6. Oct 1, 20266w ago 6-K Bullish 6/10 Entry $0.7850 to $1.69 Now $1.15 +46.50% ▲ +115.29% +113.99% vs SPY
  7. Oct 1, 20266w ago Press Release Bullish 6/10 Entry $0.7850 to $1.69 Now $1.15 +46.50% ▲ +115.29% +113.99% vs SPY
  8. Sep 24, 20267w ago 6-K Mixed 6/10 Entry $0.7760 to $1.10 Now $1.15 +48.20% ▲ +41.75% +41.97% vs SPY
  9. Sep 24, 20267w ago Press Release Mixed 5/10 Entry $0.7603 to $0.7846 Now $1.15 +51.26% ▲ +3.20% +3.61% vs SPY
  10. Sep 2, 202610w ago 6-K Bullish 7/10 Entry $0.8160 to $0.8184 Now $1.15 +40.93% ▲ +0.29% +1.25% vs SPY
Showing 10 of 28

US Market Status

Market Closed · Opens in 8h 53m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jul 24, 2026